What are The first Actions Should a Female Patient Having COVID Take?
If you or a member of your family has been diagnosed with COVID-19, you should know a few things you should do as a pregnant patient. There are travel restrictions for pregnant women with the disease and vaccination and treatment options. In addition, you may want to consider remaining home and recuperating while you get well.
Your healthcare practitioner should discuss travel limitations for pregnant women with COVID-19. The optimal time for pregnant patients to travel is during their second trimester when morning sickness is likely past and additional discomforts have not set in. However, the last trimester is challenging for pregnant women, especially those at risk for premature labor. Travel restrictions for COVID-19 may differ from state to state. However, the CDC maintains a travel restriction map.
COVID-19 is transferred by close contact and respiratory droplets that can settle on lips, noses, and lungs. As a result, pregnant women may be more susceptible to getting viral respiratory infections, making it necessary to assess the risk before traveling.
The good news for pregnant women is that the illness is rarely life-threatening. While COVID-19 can cause pneumonia in pregnant women, it is unlikely to transmit between the mother and unborn child during pregnancy. As a result, pregnant women should avoid contact with sick people.
If you believe you suffer from COVID, you must consult a doctor as soon as possible. If possible, try to remain home and avoid public transit. In addition, it would help if you avoided close contact with others, especially in crowded areas. If you can’t remain home, keep away from the public and your pets.
Vaccination is one of the first things a pregnant patient with COVID should take to safeguard her unborn child. The CDC and ACOG recommend that pregnant and breastfeeding women obtain COVID-19 immunization. The World Health Organization has also concluded that there are no harmful effects from COVID-19 immunization in pregnant women. First, though, discussing immunization with a healthcare practitioner is vital.
Immunization is free for pregnant women and unborn infants. It can be billed to insurance at no cost and is not required for undocumented individuals. In Massachusetts, vaccination is free and is available to all individuals. Those who do not have health insurance can claim payment from the federal government.
Treatment options for pregnant individuals with COVID-19 infection are limited. These women should be evaluated as soon as possible, preferably in the hospital. Who should consider their gestational age and clinical history in determining treatment options? Some patients may require intubation and admission to the intensive care unit.
A multidisciplinary team comprising obstetricians, hematologists, and internists, should evaluate the use of anticoagulants during pregnancy. The team should assess the disease’s severity and potential pregnancy complications, such as pregnancy-related bleeding. The date of delivery and other aspects must also be taken into account. If antepartum thromboprophylaxis is not an option, postpartum thromboprophylaxis should be considered if the patient is hospitalized.
Aspirin at 75 to 162 mg is generally safe during pregnancy. In addition to decreasing the risk of fetal damage, aspirin lowers the synthesis of thromboxane A2, a strong vasoconstrictor. Therefore, pregnant women with COVID-19 should be treated according to the recommendations for pregnant women.
Infection control is crucial for all healthcare facilities while treating pregnant individuals with COVID. When a pregnant woman suspects she may have COVID, it is vital to inform the obstetric unit of her condition as early as possible so that the team can make the proper preparations for labor and delivery. This involves locating the fitting room and ensuring infection control supplies are in place. The healthcare provider should also guarantee that all staff members are informed and competent to fulfill infection control guidelines.
The study included pregnant women at least 24 weeks of gestation with a documented COVID-19 infection. Nasopharyngeal RT-PCR verified the illness, and the pregnancy was watched to determine how the sickness developed. The clinical data for each patient were gathered from medical records and evaluated electronically from diagnosis until delivery. The study excluded pregnant women who were fewer than 24 weeks gestation, pregnant women with any additional comorbidities, or who had a history of malnutrition. Additionally, individuals with morbid obesity were excluded from the trial.
Comments
Post a Comment